PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30637228-1	2018	Sulfonylurea (SUR) agents are the second and most used oral hypoglycemic drugs after metformin and they still as an imperative tool for most favorable of glucose control.	Metformin	85-94	ATP binding cassette subfamily C member 8	Homo sapiens	14-17	
31231590-6	2019	Aims: To investigate the influence of SLC22A1 rs622342 (A>C) and ABCC8 rs757110 (A>C) genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian T2DM patients.	Metformin	128-137	ATP binding cassette subfamily C member 8	Homo sapiens	68-73	
12118200-4	2002	MATERIAL/METHODS: The SUR1 polymorphism was genotyped in 68 type 2 diabetic patients who required insulin treatment and had known diabetes duration L 5 years, compared to 99 patients receiving oral agents (sulfonylurea alone or in combination with metformin or acarbose) with known diabetes duration of at least 15 years.	Metformin	248-257	ATP binding cassette subfamily C member 8	Homo sapiens	22-26